Related Experiment Video
Updated: Aug 10, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
[Comparative allergologic studies in treated antihypertensive patients with vasomotor rhinitis]
Allergic mechanisms may cause nasal obstruction in patients treated for hypertension. Lymphocyte transformation tests confirmed sensitization in all patients, supported by other diagnostic methods, linking drug sensitivity to symptoms.
Area of Science:
- Allergology
- Pharmacology
- Immunology
Background:
- Nasal obstruction is a common symptom in patients undergoing antihypertensive treatment.
- The role of allergic mechanisms in this specific patient group remains unclear.
Purpose of the Study:
- To investigate the potential involvement of allergologic mechanisms in nasal obstruction among antihypertensive drug recipients.
- To determine if drug sensitization correlates with the development of nasal symptoms.
Main Methods:
- Comparison of three diagnostic methods: lymphocyte transformation test (LTT), serologico-nephelometric two-step method (Hoigné), and rat mast cell degranulation test.
- Testing conducted on patients with antihypertensive treatment experiencing nasal obstruction.
Main Results:
- Lymphocyte transformation test confirmed drug sensitization in 100% of symptomatic patients (7/7).
- Positive results from Hoigné's method and the mast cell degranulation test in 5 out of 7 patients.
- Findings suggest a link between drug sensitization and nasal symptoms.
Conclusions:
- Allergologic mechanisms, specifically drug sensitization, likely contribute to nasal obstruction in patients treated for hypertension.
- Diagnostic tests like LTT can effectively identify sensitization to medications in this context.
Related Concept Videos
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Antiasthma Drugs: Muscarinic Receptor Antagonists
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions: Anaphylaxis

